COVID-19 cases climbing ahead of Thanksgiving

The Thanksgiving travel rush is underway as coronavirus infections are skyrocketing across the country. CBS News' Bofta Yimam joins CBSN AM with more.

• Nov 23, 2020
• 5:45

ER doctor on COVID vaccine process

With one week left in November, the U.S. has already seen its highest monthly coronavirus case total. This comes as AstraZeneca announced that trials show its vaccine is up to 90% effective. CBS News' Charlie D'Agata reports on the findings, and Dr. Ron Elfenbein, medical director and owner of FirstCall Medical Center, joined CBSN to break down what we know so far about the vaccine options. He also explains why a new antibody drug approved by the FDA may be limited in the scope of who it can help.

• Nov 23, 2020
• 10:57

Pfizer seeks approval of COVID vaccine

A record 87,000 Americans tested positive for the coronavirus on Thursday, and more than 250,000 American have died since the pandemic began. On Friday, Pfizer applied for emergency authorization for its coronavirus vaccine, which could go into distribution by the end of the year. Dr. John Moore. professor of microbiology and immunology at Weill Cornell Medical College at Cornell University, joined CBSN to discuss the latest.

• Nov 20, 2020
• 10:03

Oxford-AstraZeneca vaccine showing effectiveness in older adults

Progress is quickly being made in the race for a coronavirus vaccine. AstraZeneca says the vaccine it is developing at Oxford University in London is highly effective in older adults. This is the third vaccine to show promise in recent weeks, and it could be available alongside the vaccines being developed by Pfizer and Moderna. Charlie D'Agata discusses how the AstraZeneca vaccine differs from the other two.

• Nov 19, 2020
• 2:45

ER doctor on New York City closing schools

Public schools in New York City have gone back to all-remote learning. The decision comes as a new report from the U.N. Children's Fund warns of a "lost generation" as more than 570 million students across the globe see their classroom learning impacted by the coronavirus pandemic. Dr. Dara Kass, a Yahoo News medical contributor and an ER doctor, joined CBSN to discuss what New York City and states across the country should be doing to mitigate the spread of the coronavirus.

• Nov 19, 2020
• 10:06

States tighten COVID-19 restrictions

New York City public schools are closed after the city reached a 3% positivity rate in coronavirus infections on Wednesday. As cases continue to surge across the country, many states are also reissuing restrictions and curfews, often in places where businesses remain open. Dr. David Agus joins "CBS This Morning" to discuss whether these measures are effective and what impact they have on children. He also addresses recent promising vaccine progress. The most recent testing shows AstraZeneca's vaccine developed at England's Oxford University works well, is safe, and is highly effective on older patients.

• Nov 19, 2020
• 3:38

Oxford vaccine shown to spur immune response

Scientists in England say the latest results of the Oxford COVID-19 vaccine show it's safe and provokes an immune response. It joins a growing list of vaccine candidates that have proven successful and may soon be rushed out for distribution. Charlie D'Agata reports from Oxford.

• Nov 19, 2020
• 1:37

Trials show Oxford's COVID vaccine works well in older adults

Scientists working with AstraZeneca say they're "delighted" with the latest human trial data, but they're "not in a rush."

• Nov 19, 2020

AstraZeneca says COVID-19 vaccine could arrive in January

A possible vaccine shot could come just as the U.S. is setting record highs for COVID-19 cases and hospitalizations.

• Nov 5, 2020

Doctor on rise in COVID cases and racial disparities

The CDC has published a new report that offers further insight into on populations most at risk from the coronavirus. Dr. Uché Blackstock joins CBSN to discuss the racial disparities, plus reasons behind the recent surge in cases nationwide, progress toward a vaccine, and updated guidelines for avoiding exposure.

• Oct 22, 2020
• 8:03

Moderna's COVID-19 vaccine promising for elderly

Moderna says their COVID-19 vaccine triggered an immune response just as effective in the elderly as younger adults. Internal medicine physician Dr. Shoshana Ungerleider joined CBSN with more.

• Oct 1, 2020
• 8:46

Trial of Oxford's promising COVID vaccine resumes after brief pause

Huge global trial was halted after a single participant showed a possible adverse reaction, but the U.K.'s independent safety regulator cleared it to resume.

• Sep 14, 2020

Doctor on vaccine trials, upcoming flu season

AstraZeneca announced it is pausing its phase 3 trial of a possible COVID-19 vaccine after one participant came down with an unexplained illness. Dr. Matthew Heinz joins CBSN for a closer look at what this means, plus the special concerns surrounding the coming flu season and when people should get their flu shots.

• Sep 9, 2020
• 7:56

What to know about COVID vaccine trials

Many top scientists say a coronavirus vaccine could be ready before the end of the year, and President Trump has even said it could happen by Election Day. But it's a very challenging process CBS News' Natalie Brand reports on the latest developments, and Elaine Quijano of CBSN's "Red & Blue" discussed that deadline and how scientists conduct clinical trials with Dr. Wilbur Chen, associate professor of medicine at the University of Maryland, and chief of the Adult Clinical Studies Section within the Center for Vaccine Development and Global Health.

• Sep 9, 2020
• 8:39

AstraZeneca stops COVID-19 vaccine trial

AstraZeneca abruptly halted its coronavirus vaccine trial after a participant developed neurological symptoms, but it's not yet known whether it was caused by the vaccine. Nikki Battiste reports.

• Sep 9, 2020
• 1:57

AstraZeneca pauses trial of COVID-19 vaccine

Drugmaker AstraZeneca paused its clinical trial of a COVID-19 vaccine to investigate a possible severe adverse reaction in one of the participants. This comes as the U.S. death toll from the coronavirus nears 190,000. CBS News' Elise Preston reports on the latest developments, and Dr. Neeta Ogden, an internal medicine doctor and immunologist, joined CBSN to discuss what it all means.

• Sep 9, 2020
• 9:45

Fauci on halted virus trial, "likely scenario" for vaccine timeline

Fauci stuck by his earlier projection that the safety and effectiveness of a vaccine will be known by the end of the year.

• Sep 9, 2020

Vaccine trial halted after participant has possible adverse reaction

"This is a routine action which has to happen whenever there is a potentially unexplained illness in one of the trials," an AstraZeneca spokesperson said.

• Sep 9, 2020

AstraZeneca starts phase 3 vaccine trials

Oxford University, in partnership with AstraZeneca, started testing the first U.S. volunteers as part of its phase three COVID-19 vaccine trial. CBS News chief medical correspondent Dr. Jon LaPook joins "CBS This Morning" with an exclusive interview with an American in the Oxford-AstraZeneca vaccine trial.

• Sep 1, 2020
• 3:56

Drugmakers vow to hold off on virus vaccine until it's safe

Joint pledge from nine drugmakers comes as the Trump administration is pushing for a coronavirus vaccine this fall.

• Sep 8, 2020

Antibody-based COVID drug tested

AstraZeneca is starting Phase 1 trials of a potential antibody treatment for the coronavirus. Dr. Dyan Hes joins CBSN to discuss that, plus the FDA's controversial move to approve emergency use of convalescent plasma.

• Aug 25, 2020
• 9:51

U.K. drugmaker ramping up vaccine production in record time

"That process would generally be measured in years ... So it was a sprint, to say the least."

• Aug 25, 2020

Promising vaccine trial pushes into COVID-swamped South Africa, Brazil

Oxford University team's drug is a leading contender, but there isn't enough virus still circulating in England for a trial there to work alone.

• Jun 25, 2020

AstraZeneca CEO on vaccine progress

Pascal Soriot, CEO of the pharmaceutical company AstraZeneca, says he thinks "there’s a good chance" the coronavirus vaccine they're working on with the University of Oxford will be successful. He spoke with CBS News' Charlie D'Agata about efforts to get a vaccine to the public in record time.

• May 21, 2020
• 5:09

U.S. commits $1.2 billion to production of Oxford vaccine

President Trump has launched Operation Warp Speed, which aims to make millions of doses of a coronavirus vaccine available by years end.

• May 21, 2020

Show More